N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: Randomized, placebo-controlled pilot study

Table 4 Biochemical parameters

	Group A		Group B
	Basal	4 wk	Basal	4 wk
SGOT (units/L)	16.89	16.47	20.47	25.06
SGPT (units/L)	15.58	17.53	36.94	43.59
Phosphatase alkaline (units/L)	93.56	86.61	93.59	86.71
Bilirubin (mg/100 mL)	0.68	0.67	0.50	0.51
LDH (units/L)	258.22	265.45	307.63	299.30
Serum creatinine (mg/100 mL)	0.95	0.95	0.90	0.93
Urea/BUN (mg/100 mL)	35.23	34.64	35.90	33.75
Total Proteins (g/100 mL)	7.17	7.06	7.18	7.08
Albumin (g/100 mL)	4.16	4.11	4.13	4.12
Na+ (mmol/L	138.10	139.20	138.11	139.10
K+ (mmol/L)	4.17	4.24	4.34	4.28
Glucose (mg/100 mL)	91.53	89.54	83.53	85.88
Iron (&mgr;g/dL)	70.27	69.00	78.56	84.82
Orosomucoid (mg/100 mL)	85.19	90.98	98.06	89.98
CRP (mg/L)	5.37	4.27	5.20	4.85

Group A: Mesalamine + NAC; Group B: Mesalamine + placebo.